Recruiting NA INTERVENTIONAL 2-arm NCT04731961

Reduction in Number of Botox Injections for Urgency Urinary Incontinence

Reduced Site Injection Protocol of Intra-detrusor Onabotulinumtoxin-A for Treatment of Idiopathic Refractory Urgency Urinary Incontinence

Sponsor: University of Virginia

Conditions Urgency Urinary Incontinence

Interventions Experimental Arm (5 Botox injections) Standard of care (15 Botox injections)

Updated 6 times since 2021 Last updated: Jan 26, 2025 Started: Feb 23, 2021 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Urgency Urinary Incontinence, this trial is actively recruiting participants. The trial is conducted by University of Virginia and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
Feb 2023 — Sep 2023 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Mar 2021 — Feb 2023 [monthly]

Not Yet Recruiting NA

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Virginia

Data source: University of Virginia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Charlottesville, United States